Paclitaxel and Vinca Alkaloids extravasation - Hyaluronidase

PLEASE NOTE: Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP).

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org.

1 post / 0 new

Tue, 08/13/2024 - 14:01

Scott Murray

Offline

Last seen: 13 hours 52 min ago

Joined: 06/11/2015 - 13:37

Paclitaxel and Vinca Alkaloids extravasation - Hyaluronidase

Has anyone adopted: 1 to 6ml of Hyaluronidase for each 1ml of extravasated drug into practice (Paclitaxel and Vinca Alkaloids), per "Management of Drug Extravasations" (Lexi-Drugs)?

Would you be willing to share the dosing your institution utilizes or policy?

We are not sure when it changed but prior to this it was, "Hyalurondidase 1 mL (15 units/mL) as five separate 0.2 mL injections (using a tuberculin syringe) around the site of extravasation". May have changed around December 2023?

See current excerpt:
"Hyaluronidase: If needle/cannula still in place: Administer 1 to 6 mL (150 units/mL) into existing IV line; usual dose is 1 mL for each 1 mL of extravasated drug; if needle/cannula has been removed, inject subcutaneously in a clockwise manner around area of extravasation; may repeat several times over the next 3 to 4 hours (Ener 2004)"

When you follow the references for this dosing, it is difficult to discern the evidence-based medicine behind this.

Members Log In